CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 619-624

  Hakkarainen, Tanja ^a,b   Hemminki, Akseli ^b   Pereboev, Alexander V ^b   Barker, Shannon D ^b   Asiedu, Clement K ^c   Strong, Theresa V ^c   Kanerva, Anna ^b   Wahlfors, Jarmo ^a   Curiel, David T ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; HYBRID PROTEIN; LUCIFERASE; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA;

ADENOVIRUS; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CANCER; PATHOLOGY; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ADENOVIRIDAE; ANTIGENS, CD; ANTIGENS, CD40; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037317103     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA Cancer J. Clin., 51: 15-36, 2001.
2. Hemminki, A., and Alvarez, R. D. Adenoviruses in oncology. A viable option? BioDrugs, 16: 77-87, 2002.
3. Kim, J-S., Lee, S-H., Cho, Y-S., Choi, J-J., Kim, Y. H., and Lee, J-H. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR). Gynecol. Oncol., 85: 260-265, 2002.
4. You, Z., Fischer, D. C., Tong, X., Hasenburg, A., Aguilar-Cordova, E., and Kieback, D. G. Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression. Cancer Gene Ther., 8: 168-175, 2001.
5. Krasnykh, V., Dmitriev, I., Navarro, J-G., Belousova, N., Kashentseva, E., Xiang, J., Douglas, J. T., and Curiel, D. T. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry Capacity. Cancer Res., 60: 6784-6787, 2000.
6. Hemminki, A., Belousova, N., Zinn, K. R., Liu, B., Wang, M., Chaudhuri, T. R., Rogers, B. E., Buchsbaum, D. J., Siegal, G. P., Barnes, M. N., Gomez-Navarro, J., Curiel, D. T., and Alvarez, R. D. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol. Ther., 4: 223-231, 2001.
7. Kanerva, A., Mikheeva, G. V., Krasnykh, V., Coolidge, C. J., Lam, J. T., Mahasreshti, P. J., Barker, S. D., Straughn, M., Barnes, M. N., Alvarez, R. D., Hemminki, A., and Curiel, D. T. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin. Cancer Res., 8: 275-280, 2002.
8. Haisma, H. J., Pinedo, H. M., Rijswijk, A., der Meulen-Muileman, I., Sosnowski, B. A., Ying, W., Beusechem, V. W., Tillman, B. W., Gerritsen, W. R., and Curiel, D. T. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM. Gene Ther., 6: 1469-1474, 1999.
9. Hemminki, A., Dmitriev, I., Liu, B., Desmond, R. A., Alemany, R., and Curiel, D. T. Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule. Cancer Res., 61: 6377-6381, 2001.
10. van Kooten, C. Immune regulation by CD40-CD40-1 interactions-2; Y2K update. Front Biosci., 5: 880-893, 2000.
11. Tong, A. W., Papayoti, M. H., Netto, G., Armstrong, D. T., Ordonez, G., Lawson, J. M., and Stone, M. J. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin. Cancer Res., 7: 691-703, 2001.
12. Young, L., Eliopoulos, A., Gallagher, N., and Dawson, C. CD40 and epithelial cells: across the great divide. Immunol. Today, 19: 502-506, 1998.
13. Kikuchi, T., Miyazawa, N., Moore, M. A. S., and Crystal, R. G. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. Cancer Res., 60: 6391-6395, 2000.
14. Eliopoulos, A., Davies, C., Knox, P., Gallagher, N., Afford, S., Adams, D., and Young, L. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol. Cell. Biol., 20: 5503-5515, 2000.
15. Ghamande, S., Hylander, B. L., Oflazoglu, E., Lele, S., Fanslow, W., and Repasky, E. A. Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin. Cancer Res., 61: 7556-7562, 2001.
16. Pereboev, A. V., Asiedu, C. K., Kawakami, Y., Dong, S. S., Blackwell, J. L., Kashentseva, E. A., Triozzi, P. L., Aldrich, W. A., Curiel, D. T., Thomas, J. M., and Dmitriev, I. P. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells. Gene Ther., 9: 1189-1193, 2002.
17. Moghaddami, M., Cohen, P., Stapleton, A., and Brown, M. CD40 is not detected on human prostate cancer cells by immunohistologic techniques. Urology, 57: 573-578, 2001.
18. Sabel, M., Yamada, M., Kawaguchi, Y., Chen, F., Takita, H., and Bankert, R. CD40 expression on human lung cancer correlates with metastatic spread. Cancer Immunol. Immunother., 49: 101-108, 2000.
19. Gu, D-I., Gonzalez, A. M., Printz, M. A., Doukas, J., Ying, W., D'Andrea, M., Hoganson, D. K., Curiel, D. T., Douglas, J. T., Sosnowski, B. A., Baird, A., Aukerman, S. L., and Pierce, G. F. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res., 59: 2608-2614, 1999.
20. Reynolds, P. N., Zinn, K. R., Gavrilyuk, V. D., Balyasnikova, I. V., Rogers, B. E., Buchsbaum, D. J., Wang, M. H., Miletich, D. J., Grizzle, W. E., Douglas, J. T., Danilov, S. M., and Curiel, D. T. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol. Ther., 2: 562-578, 2000.